The study of myo-inositol supplements for reducing the risk of gestational diabetes mellitus
Not Applicable
- Conditions
- Pregnancy and ChildbirthPrevention of gestational diabetes in pregnant women
- Registration Number
- ISRCTN16448440
- Lead Sponsor
- Sidra Medical and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- Female
- Target Recruitment
- 640
Inclusion Criteria
1. All pregnant women booked for prenatal care at Sidra Medicine will be approached regardless of age, language spoken or place for delivery
2. Gestational age less than 16 weeks
3. Capacity to provide informed consent
Exclusion Criteria
1. Pre-gestational diabetes
2. Booking fasting glucose of =5.1 mmol/l (92 mg/dl)
3. Women on steroids during pregnancy
4. Women using metformin for any other disorder e.g. PCOS
5. Women taking Myo-inositol as part of any supplementation
6. Cancer not in remission
7. Women who lack the capacity to provide informed consent
8. Women who had bariatric surgery
9. Involvement in another interventional trial
10. Polyhydramnios (this is a very unlikely finding before 16 weeks)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method